APA (7th ed.) Citation

Pedersen, K. B., Jelesijevic, T., Morris, T. M., Melton, S. M., Henderson, A. S., Glenn, J. F., . . . Winsauer, P. J. Chronic administration of a cannabis-derived mixture at an antihyperalgesic dose does not significantly enhance hepatotoxicity or the development of metabolic dysfunction-associated steatohepatitis in male mice. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Pedersen, Kim B., Tomislav Jelesijevic, Tamara M. Morris, Sarah M. Melton, Ashley S. Henderson, John F. Glenn, Gregory J. Davenport, Martin J. J. Ronis, and Peter J. Winsauer. Chronic Administration of a Cannabis-derived Mixture at an Antihyperalgesic Dose Does Not Significantly Enhance Hepatotoxicity or the Development of Metabolic Dysfunction-associated Steatohepatitis in Male Mice. Frontiers Media S.A.

MLA (9th ed.) Citation

Pedersen, Kim B., et al. Chronic Administration of a Cannabis-derived Mixture at an Antihyperalgesic Dose Does Not Significantly Enhance Hepatotoxicity or the Development of Metabolic Dysfunction-associated Steatohepatitis in Male Mice. Frontiers Media S.A.